NCI Division of Cancer Biology shared on LinkedIn:
“Anirban Maitra, a researcher funded by the National Cancer Institute (NCI), is advancing early detection and treatment strategies for pancreatic cancer.
According to him, the progression of pancreatic cancer research is, ‘a circular path.’ Advancements made in the laboratory influence the development of clinical trials, and trial results ultimately inform the direction of lab research.”
About Anirban Maitra
Anirban Maitra is a physician-scientist whose work focuses on understanding pancreatic cancer and finding better ways to detect and treat it. He currently serves as the Director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health and is a Professor of Pathology at NYU Grossman School of Medicine.
Before joining NYU, he held several academic and research positions at Johns Hopkins University and the University of Texas MD Anderson Cancer Center, where he also served as Scientific Director of the Sheikh Ahmed Pancreatic Cancer Research Center.
His research explores the genetic changes behind pancreatic cancer, the development of biomarkers for early detection, and new treatment approaches. He is particularly interested in bringing laboratory discoveries into clinical practice, helping turn research findings into potential advances in patient care.
You may also be interested in: